scholarly journals Challenge in diagnosis and management of lentigo maligna and lentigo maligna melanoma

Author(s):  
Ika Anggraini
2015 ◽  
Vol 2 (2) ◽  
pp. 171-178
Author(s):  
Karen L Connolly ◽  
Kishwer S Nehal ◽  
Klaus J Busam

2018 ◽  
Vol 60 (2) ◽  
pp. 118-125 ◽  
Author(s):  
Pascale Guitera ◽  
Helena Collgros ◽  
Christine M Madronio ◽  
Christopher Goumas ◽  
Graham J Mann ◽  
...  

2021 ◽  
Vol 2021 ◽  
pp. 1-7
Author(s):  
Piyu Parth Naik

Lentigo maligna (LM), also known as Hutchinson’s melanotic freckle, is a form of in situ melanoma characterized by the proliferation of atypical melanocytes along the basal epidermis in sun-damaged skin. If left untreated, LM will progress to lentigo maligna melanoma (LMM), a form of invasive melanoma with the same prognosis as other forms of invasive melanoma. LM is more common in the elderly, with a peak occurrence between the ages of 65 and 80 years. LM, however, is rarely present on the trunk and extremities. The diagnosis of LM, confirmed by histopathological and biopsy examination, is based on clinical and dermoscopic features. It typically begins as a tan-brown macule or patch, but it can progress to a variegated pigmentation with dark black color or even amelanotic characteristics. The risk factors involved in the LM development include a history of sunburns, lighter skin types, advanced age, history of nonmelanoma skin cancers, and tendency to form solar lentigines. This article explains the clinical presentation of LM, also reviews the available information on the diagnosis and management of LM, and discusses the potential of such information in facilitating the future prospective.


2007 ◽  
Vol 57 (4) ◽  
pp. 659-664 ◽  
Author(s):  
Hobart W. Walling ◽  
Richard K. Scupham ◽  
Andrew K. Bean ◽  
Roger I. Ceilley

2018 ◽  
Vol 45 (5) ◽  
pp. 564-570 ◽  
Author(s):  
Clara Matas-Nadal ◽  
Xavier Sòria ◽  
María R. García-de-la-Fuente ◽  
Valentín Huerva ◽  
Eugenia Ortega ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document